Tender Number 1

This tender, designated as Tender Number 1 (sub-contract), pertains to the procurement of specific pharmaceutical products. The primary focus is on the drug Sutimlimab, identified by the ATC code L04AJ04. This medication is to be supplied in the form of an infusion solution, with a strength of 50 mg/ml and a unit value of 0.46 g. The estimated quantity required is 375 units. Each tender number is treated as an independent sub-contract, and bids will be evaluated separately for each. Suppliers have the flexibility to submit offers for one, multiple, or all available tender numbers, with contract awards made on an individual basis per tender number. Consequently, a single supplier may be awarded one, several, or all of the sub-contracts. Interested parties are directed to the tender conditions for detailed information regarding the submission of bids for each specific tender number. The quantity indicated as 'quantity in units' represents an estimated consumption of the medication under this tender number. However, it is crucial for suppliers to note that the actual consumption may vary significantly. This variability is due to the nature of supplying pharmaceuticals for patient treatment in public hospitals, where patient needs dictate the actual demand. For a comprehensive understanding of the requirements and the framework agreement, please refer to the official tender documentation.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Denmark, Europe, this opportunity is open to firms and consortiums, with an estimated budget of DKK 4.9 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.